These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks: one year of follow-up. El Matri L; Kort F; Bouraoui R; Karim B; Chebil A; Chaker N Acta Ophthalmol; 2011 Nov; 89(7):641-6. PubMed ID: 21155980 [TBL] [Abstract][Full Text] [Related]
3. Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum. Finger RP; Charbel Issa P; Schmitz-Valckenberg S; Holz FG; Scholl HN Retina; 2011; 31(7):1268-78. PubMed ID: 21386758 [TBL] [Abstract][Full Text] [Related]
4. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks. Sawa M; Gomi F; Tsujikawa M; Sakaguchi H; Tano Y Am J Ophthalmol; 2009 Oct; 148(4):584-590.e2. PubMed ID: 19541288 [TBL] [Abstract][Full Text] [Related]
12. Combination treatment with intravitreal injection of ranibizumab and reduced fluence photodynamic therapy for choroidal neovascularization secondary to angioid streaks: preliminary clinical results of 12-month follow-up. Artunay O; Yuzbasioglu E; Rasier R; Sengul A; Senel A; Bahcecioglu H Retina; 2011; 31(7):1279-86. PubMed ID: 21394063 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks: a long-term follow-up study. Rosina C; Romano M; Cigada M; de Polo L; Staurenghi G; Bottoni F Eur J Ophthalmol; 2015; 25(1):47-50. PubMed ID: 25044143 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for treatment of subfoveal idiopathic choroidal neovascularization: results of a 1-year prospective trial. Zhang H; Liu ZL; Sun P; Gu F Am J Ophthalmol; 2012 Feb; 153(2):300-306.e1. PubMed ID: 21982109 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal ranibizumab treatment of macular choroidal neovascularization secondary to angioid streaks: one-year results of a prospective study. Ladas ID; Kotsolis AI; Ladas DS; Niskopoulou M; Georgalas I; Papakonstantinou D; Rouvas AA Retina; 2010 Sep; 30(8):1185-9. PubMed ID: 20539257 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum. Bhatnagar P; Freund KB; Spaide RF; Klancnik JM; Cooney MJ; Ho I; Fine HF; Yannuzzi LA Retina; 2007 Sep; 27(7):897-902. PubMed ID: 17891014 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization. Yoon JU; Kim YM; Lee SJ; Byun YJ; Koh HJ Retina; 2012 May; 32(5):949-55. PubMed ID: 22534553 [TBL] [Abstract][Full Text] [Related]
18. A case of intravitreal bevacizumab injection for the treatment of choroidal neovascularization in angioid streaks. Lee JW; Shin JP; Kim SY Korean J Ophthalmol; 2011 Jun; 25(3):218-21. PubMed ID: 21655051 [TBL] [Abstract][Full Text] [Related]
19. Results of 1-year follow-up examinations after intravitreal bevacizumab administration for idiopathic choroidal neovascularization. Inoue M; Kadonosono K; Watanabe Y; Sato S; Kobayashi S; Yamane S; Ito R; Arakawa A Retina; 2010 May; 30(5):733-8. PubMed ID: 20168271 [TBL] [Abstract][Full Text] [Related]
20. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]